Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2015 3
2016 8
2017 6
2018 7
2019 10
2020 6
2021 6
2022 6
2023 5
2024 7
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Author profile: Paula Nieto Morales.
Morales PN. Morales PN. Cytoskeleton (Hoboken). 2024 Dec;81(12):913-914. doi: 10.1002/cm.21914. Epub 2024 Aug 31. Cytoskeleton (Hoboken). 2024. PMID: 39215700 No abstract available.
CBD: A New Hope?
Morales P, Reggio PH. Morales P, et al. ACS Med Chem Lett. 2019 Apr 29;10(5):694-695. doi: 10.1021/acsmedchemlett.9b00127. eCollection 2019 May 9. ACS Med Chem Lett. 2019. PMID: 31097982 Free PMC article.
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.
Calvillo-Robledo A, Cervantes-Villagrana RD, Morales P, Marichal-Cancino BA. Calvillo-Robledo A, et al. Among authors: morales p. Life Sci. 2022 Jul 15;301:120596. doi: 10.1016/j.lfs.2022.120596. Epub 2022 Apr 30. Life Sci. 2022. PMID: 35500681 Review.
Editorial: Cannabinoids as potential treatment for neurological diseases.
Gómez-Cañas M, Morales P, Satta V, Rodríguez-Cueto C, García C, Sagredo O. Gómez-Cañas M, et al. Among authors: morales p. Front Neurosci. 2022 Dec 20;16:1108101. doi: 10.3389/fnins.2022.1108101. eCollection 2022. Front Neurosci. 2022. PMID: 36605545 Free PMC article. No abstract available.
Cannabinoid Ligands Targeting TRP Channels.
Muller C, Morales P, Reggio PH. Muller C, et al. Among authors: morales p. Front Mol Neurosci. 2019 Jan 15;11:487. doi: 10.3389/fnmol.2018.00487. eCollection 2018. Front Mol Neurosci. 2019. PMID: 30697147 Free PMC article. Review.
Editorial: New approaches for the discovery of GPCR ligands.
Morales P, Scharf MM, Johnson CP, Di Pizio A, Hilger D. Morales P, et al. Front Endocrinol (Lausanne). 2023 Aug 21;14:1272700. doi: 10.3389/fendo.2023.1272700. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37670881 Free PMC article. No abstract available.
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Morales P, Lago-Fernandez A, Hurst DP, Sotudeh N, Brailoiu E, Reggio PH, Abood ME, Jagerovic N. Morales P, et al. J Med Chem. 2020 Dec 10;63(23):14216-14227. doi: 10.1021/acs.jmedchem.0c00926. Epub 2020 Sep 23. J Med Chem. 2020. PMID: 32914978 Free PMC article. Review.
Progress on the development of Class A GPCR-biased ligands.
Morales P, Scharf MM, Bermudez M, Egyed A, Franco R, Hansen OK, Jagerovic N, Jakubík J, Keserű GM, Kiss DJ, Kozielewicz P, Larsen O, Majellaro M, Mallo-Abreu A, Navarro G, Prieto-Díaz R, Rosenkilde MM, Sotelo E, Stark H, Werner T, Wingler LM. Morales P, et al. Br J Pharmacol. 2025 Jul;182(14):3249-3300. doi: 10.1111/bph.17301. Epub 2024 Sep 11. Br J Pharmacol. 2025. PMID: 39261899 Review.
69 results